PSYCHEDELIC DRUGS MARKET Size and trends

Psychedelic Drugs Market, By Drug Type (Gamma Hydroxybutyric Acid, Ketamine, Psilocybin, Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and Other Drug Types), By Application (Mental Health Disorders, Neurological Disorders, Pain Management, and Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Route of administration (Oral, Intravenous, Inhalation, Intranasal, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI7527
Pages :140
Formats :
Excel and PDF
Industry : Pharmaceutical

Psychedelic Drugs Market Size and Trends

The Global Psychedelic Drugs Market is estimated to be valued at USD 3.88 Bn in 2025 and is expected to reach USD 9.60 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2025 to 2032. Psychedelic drugs are a class of hallucinogenic drugs including psilocybin, lysergic acid diethylamide (LSD), ketamine, and others. These drugs are reported to have potential in treatment of serious mental health conditions.

Psychedelic Drugs Market Key Factors

To learn more about this report, Request sample copy

The global psychedelic drugs market is witnessing high growth owing to increasing research activities involving psychedelic drugs for treating mental health disorders. Psychedelic drugs like psilocybin, 3,4-methylenedioxymethamphetamine (MDMA), and ketamine are under clinical trials and have shown promising results for treatment resistant depression, Post-Traumatic Stress Disorder (PTSD), opioid addiction, and other mental health conditions.

PSYCHEDELIC DRUGS MARKET Size and trends

Psychedelic Drugs Market Size and Trends

Psychedelic Drugs Market Report Snapshots

EXISTING CLIENTELE